Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Hematological Disorders in Afghanistan: A Review.

Created on 09 Sep 2026

Authors

Halima Ismailzada, Mohammadreza Ghorbani, Sayed Mortaza Fayez

Published in

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. Volume 42. Issue 5. Pages 1639-1646. Epub Jul 11, 2026.

Abstract

Afghanistan faces a heavy and largely under‑recognized burden of hematological disorders, shaped by a uniquely complex interplay of high consanguinity, population‑specific genetic variants, widespread nutritional deficiencies, extreme environmental conditions, and decades of armed conflict. The national consanguinity rate (~ 46%) drives some of the world's highest prevalences of autosomal recessive hemoglobinopathies, particularly β‑thalassemia, with 1-1.5 million estimated carriers. β‑thalassemia carrier rates vary sharply by ethnicity, reaching 5-10% in Pashtun and Tajik groups, while the α‑globin novel mutation Hb Balkh has been identified in the central highlands of Aghaninstan. G6PD deficiency, predominantly the Mediterranean type, affects up to 8.9% of Pashtun males and make a barrier to cure malaria with primaquine. Nutritional anemias are equally pervasive: anemia affects 51% of pregnant women in some provinces, 44.2% of children under five have iron deficiency, and 25% of newly arrived Afghan refugees have vitamin B12 deficiency. Conflict aggravates every dimension of the hematologic disease burden trauma‑induced coagulopathy, a largely voluntary blood supply with transfusion‑transmissible infection markers in 4.36% of donations (HBV 2.95%, HCV 0.81%), and the near‑absence of newborn screening, HPLC, or molecular diagnostics. Management relies on splenectomy and irregular transfusions; premarital screening is not mandated. This review synthesizes peer‑reviewed evidence (2000-2026) to provide the first comprehensive narrative of hematological disorders in Afghanistan, critically appraises diagnostic and therapeutic gaps against regional standards, and proposes a pragmatic research and intervention agenda.
Geographic and thematic overview of hematological disorders in Afghanistan. The map of Afghanistan and neighboring countries (Turkmenistan, Tajikistan, China, Iran, Pakistan) highlights key drivers and disease hotspots. Major contributing factors include: (i) high consanguinity rates and genetic disorders (β thalassemia, hemoglobinopathies, G6PD deficiency); (ii) environmental pollution and toxic exposures; (iii) conflict, war instability, and poor healthcare infrastructure; and (iv) rare blood disorders. The convergence of these factors creates distinct hematological disease hotspots across the country, with Pashtun and Tajik populations showing higher thalassemia carrier rates and conflict-affected regions facing diagnostic and treatment gaps.

PMID:
42712625
Bibliographic data and abstract were imported from PubMed on 09 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement